Laura J. Esserman

1983–2025 年に発表

別表記
LAURA J. ESSERMAN
211
論文数
27,968
被引用数
90
h 指数
195
i10 指数

被引用数

Laura J. Esserman の年別被引用数1982 年: 被引用 1 件1984 年: 被引用 3 件1985 年: 被引用 4 件1986 年: 被引用 2 件1987 年: 被引用 2 件1988 年: 被引用 1 件1989 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 6 件1993 年: 被引用 5 件1994 年: 被引用 2 件1995 年: 被引用 3 件1996 年: 被引用 5 件1997 年: 被引用 6 件1998 年: 被引用 3 件1999 年: 被引用 11 件2000 年: 被引用 20 件2001 年: 被引用 12 件2002 年: 被引用 21 件2003 年: 被引用 31 件2004 年: 被引用 43 件2005 年: 被引用 45 件2006 年: 被引用 71 件2007 年: 被引用 107 件2008 年: 被引用 131 件2009 年: 被引用 124 件2010 年: 被引用 160 件2011 年: 被引用 156 件2012 年: 被引用 178 件2013 年: 被引用 247 件2014 年: 被引用 306 件2015 年: 被引用 286 件2016 年: 被引用 267 件2017 年: 被引用 328 件2018 年: 被引用 270 件2019 年: 被引用 814 件2020 年: 被引用 976 件2021 年: 被引用 999 件2022 年: 被引用 762 件2023 年: 被引用 698 件2024 年: 被引用 1,153 件2025 年: 被引用 593 件2026 年: 被引用 26 件1983 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,529 件、この内訳の 28.7%中国: 引用元論文 1,077 件、この内訳の 8.8%イギリス: 引用元論文 885 件、この内訳の 7.2%イタリア: 引用元論文 615 件、この内訳の 5%ドイツ: 引用元論文 522 件、この内訳の 4.3%カナダ: 引用元論文 463 件、この内訳の 3.8%フランス: 引用元論文 435 件、この内訳の 3.5%スペイン: 引用元論文 383 件、この内訳の 3.1%オランダ: 引用元論文 370 件、この内訳の 3%オーストラリア: 引用元論文 368 件、この内訳の 3%ベルギー: 引用元論文 273 件、この内訳の 2.2%スウェーデン: 引用元論文 242 件、この内訳の 2%
0%28.7%その他 25.4%

分野

  • Medicine46.6%
  • Biochemistry, Genetics and Molecular Biology41.9%
  • Immunology and Microbiology4.2%
  • Computer Science2.5%
  • Health Professions1%
  • Engineering0.8%
  • その他3%

トピック

  • Breast Cancer Treatment Studies9.5%
  • Cancer Genomics and Diagnostics4.1%
  • Cancer Immunotherapy and Biomarkers3.5%
  • Breast Lesions and Carcinomas3.3%
  • Radiomics and Machine Learning in Medical Imaging3%
  • Cancer Cells and Metastasis2.9%
  • その他73.7%

共著者

全論文

検索で開く
  1. Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 438

  2. Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey B. Matthews, Scott Berry, Ashish Sanil, Richard B. Schwab, W. Fraser Symmans, Laura van ‘t Veer, Douglas Yee, Angela DeMichele, Nola M. Hylton, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, Donald A. Berry, Laura J. Esserman - JAMA Oncology 2020 被引用: 706

  3. Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gillian L. Hirst, Laura J. Esserman, Laura van ‘t Veer - Cancer Cell 2022 被引用: 326

  4. Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott Berry, Ashish Sanil, Adam L. Asare, Jeffrey B. Matthews, Jane Perlmutter, Michelle Melisko, Hope S. Rugo, Richard B. Schwab, W. Fraser Symmans, Douglas Yee, Laura J. van’t Veer, Nola M. Hylton, Angela DeMichele, Donald A. Berry, Laura J. Esserman - Cancer Cell 2021 被引用: 330

  5. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura van ‘t Veer - Cancer Cell 2023 被引用: 171

  6. Personalized early detection and prevention of breast cancer: ENVISION consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Devilee, Suzette Delaloge, Marjanka K. Schmidt, Martin Widschwendter - Nature Reviews Clinical Oncology 2020 被引用: 439

  7. Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erica Stringer-Reasor, Anne M. Wallace, Lajos Pusztai, Judy C. Boughey, Erin D. Ellis, Anthony Elias, Janice Lu, Julie E. Lang, Hyo S. Han, Amy S. Clark, Rita Nanda, Donald W. Northfelt, Qamar J. Khan, Rebecca K. Viscusi, David Euhus, Kirsten K. Edmiston, Jane Yuet Ching Hui, Kathleen Kemmer, John W. Park, Minetta C. Liu, Olufunmilayo I. Olopade, Brian Leyland‐Jones, Debasish Tripathy, Stacy L. Moulder, Hope S. Rugo, Richard B. Schwab, Shelly S. Lo, Teresa Helsten, Heather Beckwith, Patricia Haugen, Nola M. Hylton, Laura J. van’t Veer, Jane Perlmutter, Michelle Melisko, Amy Wilson, Garry Peterson, Adam L. Asare, Meredith Buxton, Melissa Paoloni, Julia L. Clennell, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Jeffrey B. Matthews, Smita Asare, Ashish Sanil, Scott Berry, Laura J. Esserman, Donald A. Berry - JAMA Oncology 2020 被引用: 225

  8. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly K. Hunt - Journal of Clinical Oncology 2017 被引用: 411

  9. Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study

    著者: , , , , , , , , , , , , , , , , , , , - Radiology 2023 被引用: 87

  10. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel - JNCI Journal of the National Cancer Institute 2018 被引用: 282

  11. Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Haley, Rita Nanda, Donald W. Northfelt, Debasish Tripathy, William C. Wood, Cheryl A. Ewing, Richard B. Schwab, Julia Lyandres, Sarah Davis, Gillian L. Hirst, Ashish Sanil, Donald A. Berry, Laura J. Esserman - New England Journal of Medicine 2016 被引用: 555

  12. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

    著者: , , , , , , , , , , , , , , , - Radiology 2015 被引用: 277

  13. Guiding principles for the responsible development of artificial intelligence tools for healthcare

    著者: , , - Communications Medicine 2023 被引用: 76

  14. Leukocyte composition of human breast cancer

    著者: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 473

  15. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial

    著者: , , , , , , , , , , , , , , , , , , , - Radiology 2018 被引用: 284

  16. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial

    著者: , , , , , , , , , - JNCI Journal of the National Cancer Institute 2016 被引用: 246

  17. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2006 被引用: 1,320

  18. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kathy S. Albain, Rashmi K. Murthy, Judy C. Boughey, Minetta C. Liu, Barbara Haley, Anthony Elias, Amy S. Clark, Kathleen Kemmer, Claudine Isaacs, Julie E. Lang, Hyo S. Han, Kirsten K. Edmiston, Rebecca K. Viscusi, Donald W. Northfelt, Qamar J. Khan, Brian Leyland‐Jones, Sara J. Venters, Sonal Shad, Jeffrey B. Matthews, Smita Asare, Meredith Buxton, Adam L. Asare, Hope S. Rugo, Richard B. Schwab, Teresa Helsten, Nola M. Hylton, Laura van ‘t Veer, Jane Perlmutter, Angela DeMichele, Douglas Yee, Donald A. Berry, Laura J. Esserman - JAMA Oncology 2021 被引用: 106

  19. Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 560

  20. Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

    著者: , , , , , , , , , , , , - Radiology 2012 被引用: 489

  21. The WISDOM Study: breaking the deadlock in the breast cancer screening debate

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elad Ziv - npj Breast Cancer 2017 被引用: 280

  22. Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 75

  23. The Integration of Clinical Trials With the Practice of Medicine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven R. Cummings, Gregory Curfman, Laura J. Esserman, Lee A. Fleisher, Joseph B. Franklin, Ralph Gonzalez, Cynthia Grossman, Tufia C. Haddad, Roy S. Herbst, Adrian F. Hernandez, Diane Holder, Leora Horn, Grant D. Huang, Alison J. Huang, Nancy Kass, Rohan Khera, Walter J. Koroshetz, Harlan M. Krumholz, Martin Landray, Roger Lewis, Tracy A. Lieu, Preeti Malani, Christa Lese Martin, Mark McClellan, Mary Mcdermott, Stephanie R. Morain, Susan A. Murphy, Stuart G. Nicholls, Stephen J. Nicholls, Peter J. O’Dwyer, Bhakti K. Patel, Eric C. Peterson, Sheila A. Prindiville, Joseph S. Ross, Kathy Rowan, Gordon D. Rubenfeld, Christopher Seymour, Rod S Taylor, Joanne Waldstreicher, Tracy Y. Wang - JAMA 2024 被引用: 70

  24. Whole-genome analysis informs breast cancer response to aromatase inhibition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julie A. Margenthaler, Gildy V. Babiera, P. Kelly Marcom, J. Michael Guenther, Marilyn Leitch, Kelly K. Hunt, John A. Olson, Tao Yu, Christopher A. Maher, Lucinda Fulton, Robert S. Fulton, Michelle Harrison, Ben Oberkfell, Feiyu Du, Ryan Demeter, Tammi L. Vickery, Adnan Elhammali, Helen Piwnica‐Worms, Sandra McDonald, Mark A. Watson, David J. Dooling, David M. Ota, Li-Wei Chang, Ron Bose, Timothy J. Ley, David Piwnica‐Worms, Joshua M. Stuart, Richard K. Wilson, Elaine R. Mardis - Nature 2012 被引用: 1,035